Article

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Halatsch, M.E., Kast, R.E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Mayer-Steinacker, R., Schmidt, C., Zeiler, K., Elshaer, Z., Panther, P., Schmelzle, B., Hallmen, A., Dwucet, A., Siegelin, M.D., Westhoff, M.A., Beckers, K., Bouche, G. and Heiland, T.
Neuro-Oncology Advances 3 (1): vdab075. 7 August 2021

Long-lived tumor-associated macrophages in glioma.
Georgieva, P.B. ORCID: https://orcid.org/0000-0002-6347-2297, Mathivet, T., Alt, S. ORCID: https://orcid.org/0000-0003-1877-2968, Giese, W. ORCID: https://orcid.org/0000-0003-0872-0929, Riva, M., Balcer, M. and Gerhardt, H. ORCID: https://orcid.org/0000-0002-3030-0384
Neuro-Oncology Advances 2 (1): vdaa127. 9 November 2020